Please assess the completion status of the following clinical trial:

Trial Title: Growth Hormone Deficiency in Adults (GHDA)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with diagnosed GHD~* If the subject has a history of treatment of treatment for a tumour of pituitary or peripheral site, two years or more must have passed since completion of surgery, radiotherapy or other treatment, and recurrence of the underlying disease to be excluded~* Appropriate replacement therapy has been administered for more than 24 weeks for the treatment of other pituitary hormone deficiencies~Exclusion Criteria:~* Subject with a history of acromegaly~* Subject with diabetes mellitus~* Subject suffering from malignancy~* Several medical conditions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).